A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

Clinical trial NCT00799136 · COMPLETED

Trial details

NCT number: NCT00799136
Sponsor: Ontario Clinical Oncology Group (OCOG)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, AIDS Related HIV Infections

Start date: 2008-02-01
Primary completion: 2012-12-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.